High-Speed DNA Synthesis to Drive Growth in Synthetic Biology Market

Advancements in High-Speed DNA Synthesis to Drive Growth in the Global Synthetic Biology Market

Advancements in High-Speed DNA Synthesis to Drive Growth in the Global Synthetic Biology Market, According to New Report by Global Industry Analysts, Inc. 

GIA announces the release of a comprehensive global report on Synthetic Biology markets. Global market for Synthetic Biology is projected to reach US$12.9 billion by 2018, driven by advances in high-speed DNA synthesis and DNA sequencing.

[caption id="attachment_144" align="aligncenter" width="500"] High-Speed DNA Synthesis to Drive Growth in Synthetic Biology Market[/caption]

San Jose, California (PRWEB) November 26, 2013

Follow us on LinkedIn - Synthetic biology as an extension of biotechnology and genetic engineering, is expected to present a new world of opportunities right from designing new biological systems to entirely transforming the way food crops or medicines are developed. Unlike genetic engineering, in synthetic biology, scientists entirely reengineer biological systems by writing a new genetic code on a computer, which is later impregnated into organisms for creating an artificial life form. Though synthetic biology is still in its infancy, the potential for future impact remains significant. The revolutionary idea brings together multiple disciplines such as computer modeling, engineering and biological sciences for creating next-generation biological systems, parts and devices as well as for redesigning existingbiological systems for useful applications. Molecular biologists, computer scientists, engineers and chemists are working in collaboration to develop building blocks for creating a new synthetic world, while researchers are exploring the process of gene manipulation as well as reconfiguration of metabolic pathways of cells to perform new functions. Ever since its inception, synthetic biology has played a pioneering role in transforming applications across diverse end-use segments including agriculture, pharmaceuticals, energy and healthcare. Several of the leading chemical, energy, pharmaceutical, food, forestry and agribusiness companies are investing in synthetic biology research and are increasingly relying on artificial DNA fragments to invent new products.

As stated by the new market research report on, Synthetic Biology, Europe represents the largest market worldwide, supported by high R&D interest in developing synthetic biology based products. Within Europe, Germany, the UK and Scotland remain prominent markets. Japan, India and China are expected to drive future growth in the market.

Synthetic biology has potential applications in a number of areas, including health, environment, energy, food and agriculture and new materials development. Energy & Chemicals represent the largest as well as the fastest growing end-use sector. Within the pharmaceuticals sector, the technology has pioneered the development of an affordable and highly-effective malaria drug, which offers therapeutic benefits similar to Artemisia, a Chinese herb. The new drug is produced inside the cellular membranes of a synthetic yeast strain. In the agriculture sector, the technology finds utility in the production of genetically-engineered crops. Currently, genetically-engineered crops contribute about 94% of cotton, 93% of soy, and 88% of corn of the overall acreage in the United States. The technology is being used to develop high-performance biofuels. Other areas with commercial potential include the use of synthetic biology for creating crop-enhancing fertilizers and new food additives, such as artificial sweeteners. The technology can also be used to modify the genetic code of naturally-found bacteria in the soil so that it releases growth hormones in soil for the plant to absorb the hormone and develop stronger roots. Synthetic biology can also be used to create gene network for endangered species, facilitate artificial photosynthesis, and perform biological computing.

Major players covered in the report include Agilent Technologies Inc., Amyris Biotechnologies Inc., BP PLC, Chromatin Inc., DuPont, Gevo Inc., 454 Life Sciences, Epoch Life Science Inc., Evolva SA, Solazyme Inc., Synthetic Genomics Inc., Synthetic Biologics Inc., DNA2.0, Intrexon Corp, and Life Technologies, among others.

The research report titled "Synthetic Biology: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, drivers, issues, and strategic industry activities of major companies worldwide. The report provides market estimates and projections for geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific and Rest of World. The report analyzes the global market for synthetic biology by end-use sector - Energy & Chemicals, Biotechnology & Pharmaceuticals and Research & Development.

For more details about this comprehensive market research report, please visit -http://www.strategyr.com/Synthetic_Biology_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

News Release Source : http://www.prweb.com/releases/synthetic_biology_market/bioengineering_industry/prweb11371207.htm

Synthetic biology research community grows significantly

Synthetic biology research community grows significantly

 

Update to synthetic biology map identifies new activity across the globe

WASHINGTON – The number of private and public entities conducting research in synthetic biology worldwide grew significantly between 2009 and 2013, according to the latest version of an interactive map produced by the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars. The map is available online at http://www.synbioproject.org/map.

[caption id="attachment_138" align="aligncenter" width="450"] Synthetic biology research community grows significantly[/caption]

Synthetic biology, an area of research focused on the design and construction of new biological parts and devices, or the re-design of existing biological systems, is an emerging field and the focus of labs and companies around the world. The map, which builds on work the project started in 2009, is populated with more than 500 companies, universities, research institutions and other entities working on synthetic biology, showing clusters of activity in California, Massachusetts, Western Europe and East Asia.

"Part of this new activity has been driven by continuing government investments in the science," said David Rejeski, who directs the Synthetic Biology Project. "Another important factor has been the rapidly declining costs of gene sequencing, which has supported more effective approaches to engineering biological systems."

The Synthetic Biology Project found that the number of companies conducting synthetic biology research increased three-fold since 2009. A plurality of the companies involved in synthetic biology is focusing on developing bio-based specialty chemicals, fuels and/or medicines.

Since 2009, the industry has also experienced moderate levels of consolidation and failure. Of the 61 companies included on the initial 2009 inventory, six were acquired by other companies, closed their doors or can longer be identified. An additional 11 companies that were tracked between the release of the 2009 inventory and the 2013 update were also acquired, closed or cannot be identified.

In addition to the expanded listings, the updated map features improved functionality, more detailed information and additional categories and subcategories. The updated map can also be accessed on Android and Apple mobile devices.

The map can be found here: http://www.synbioproject.org/map

The 2013 analysis can be found here: http://www.synbioproject.org/process/assets/files/6302/_draft/findings_2013.pdf

The map will be updated periodically. Users can submit additional entries to the map using this online form: http://www.synbioproject.org/sbmap/add-item/

About the Synthetic Biology Project

About the Synthetic Biology Project

The Synthetic Biology Project is an initiative of the Woodrow Wilson International Center for Scholars supported by a grant from the Alfred P. Sloan Foundation. The project aims to foster informed public and policy discourse concerning the advancement of synthetic biology. For more information, visit: http://www.synbioproject.org

About The Wilson Center

The Wilson Center provides a strictly nonpartisan space for the worlds of policymaking and scholarship to interact. By conducting relevant and timely research and promoting dialogue from all perspectives, it works to address the critical current and emerging challenges confronting the United States and the world. For more information, visit: http://www.wilsoncenter.org

 

Top Ten Suppliers of Synthetic Biology Technology

Top Ten Suppliers of Synthetic Biology Technology

RnRMarketResearch.com adds latest report on “Top Ten Suppliers of Synthetic Biology Technology” to its store.

Dallas, Texas (PRWEB) March 12, 2013

Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical engineering. According to physicist Freeman Dyson, “The ability to design and create new forms of life marks a turning point in the history of our species and our planet.”

[caption id="attachment_128" align="aligncenter" width="350"] Top Ten Suppliers of Synthetic Biology Technology[/caption]

These advances also mark an economic turning point, creating a market vision of synthetic biology life forms and life processes tailored to produce specific substances. The desired yield of such substances as biofuels can be measured in millions of tons, whereas pharmaceuticals can be measured in grams or milligrams.

The door that is opening is likely to affect important markets for decades. Intense research and development continues to be both privately and publicly funded, but the work has emphatically moved out of the laboratory and into the marketplace. Major corporations are putting new intellectual properties to work in new factories in the U.S. and abroad.

The players on this new field include new companies that come directly out of university research riding large holdings of intellectual property and established multinational giants that have the networks necessary to distribute and market the new materials.

Between these two ends of the spectrum, companies are emerging that can intermediately supply the substances and services that bridge the gaps. The result is intricate patterns of interconnection between layers of the new supply chains. Acquisitions up and down these supply chains are frequent, as capital is freely available due to the obvious potential.

This document examines 10 of the top companies in the field and discusses their positions in these complex patterns of supply and demand, as well as their investments and alliances. The chosen companies have effectively positioned themselves to connect the ends of the chain from the specialized tools and materials end or acquired the ability to make the most effective use of these tools and materials.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=83727

This Research selected 10 companies that deserve recognition as leaders in the industry. Some are large established multinationals that have embraced the new technology. Others are startup pioneers that grow directly out of the research and development process. They are:
Life Technologies
DNA2.0
Origene
Synthetic Genomics
DuPont
Pfizer
Novozymes
Amrys Biotechnologies
Scarab Genomics
British Petroleum

Any top 10 list has subjective elements, and thus five other companies are profiled in less detail.

Study Goals And Objectives
This document is a specialty report related to this research report BIO066B by John Bergin. The goal of this document is to provide a more in-depth look at the top-tier synthetic biology companies, as well as some of the second-tier companies that are sure to play important roles in the years to come. More specifically, the objectives include identifying companies that are considered the leaders in their fields, as well as the technological means these companies are using to exploit their markets and dominate their fields.

Synthetic biology markets reviewed in this report include:
Markets by end-use segment, such as research and development (R&D), diagnostics/pharmaceuticals, energy, chemicals, and agriculture.
Markets by product type, including enabling products, biologic components, integrated systems, and enabled products.

Other major factors used to determine top companies in the field include:
Alliances, mergers, and acquisition strategies.
Financing.
Intellectual property (i.e., patent) portfolios.

Intended Audience
The study compiles existing and future synthetic biology products and technologies that will be commercially important in the main end -user segments of life science research, pharmaceuticals, diagnostics, energy, chemicals, and agriculture.

This report will be of particular interest to pharmaceutical, chemical, enzyme, energy, agricultural, biotechnology and nanobiotechnology companies, as well as suppliers of genomics tools, DNA synthesis and DNA-sequencing products. It will also help professionals within governments and regulatory agencies to understand the scope and pace of synthetic biology technologies as they reach the market.

Scope
This report focuses on 10 selected synthetic biology companies and the key areas in the field driving the industry growth that allows these companies to succeed. Key market segments include synthetic genes, chassis organisms, biofuels, specialty chemicals and pharmaceuticals. Another key area is industry structure, with a focus on strategic alliances and acquisitions, as well as pertinent patent information.

Methodology
Based on primary and secondary market analysis, this report analyzes the top 10 companies in DNA sequencing, as well as several additional companies worth recognizing.

Browse more reports on Genetic Engineering Industry @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/genetic-engineering. Explore other newly published reports @http://www.rnrmarketresearch.com/latest_reports.

About Us:
RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.